MarketWatch (press release) NEW PROVIDENCE, N.J., Jul 12, 2013 (BUSINESS WIRE) -- Edge Therapeutics today announced that researchers from Heinrich Heine University in Dusseldorf, Germany presented positive results of the first clinical application of EG-1962 ( nimodipine ... and more »
The Hindu Last year, the Mumbai-based firm had recalled one lot of the drug as a precautionary measure due to the presence of nimodipine crystals within the capsule solution. Nimodipine Capsules, 30 mg, are used to decrease problems due to subarachnoid ... and more »
BFMTV.COM Edge Therapeutics a annoncé que des chercheurs de l'université Heinrich Heine de Düsseldorf en Allemagne ont présenté des résultats positifs issus de la première application clinique de l'EG-1962 (microparticules de nimodipine ), une formulation de ...
PipelineReview.com (press release) NEW PROVIDENCE, NJ, USA & DÜSSELDORF, Germany I June 27, 2013 I Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for ... and more »
EON: Enhanced Online News (press release) NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Edge Therapeutics today announced that researchers from Heinrich Heine University in Düsseldorf, Germany presented positive results of the first clinical application of EG-1962 ( nimodipine microparticles), ... and more »
